Latest Safety News

Imagion Biosystems is set to submit its Investigational New Drug application for the MagSense® HER2 breast cancer imaging agent in December 2025, paving the way for a Phase 2 clinical trial in early 2026. Collaboration with Wayne State University has refined the trial design, promising improved patient safety and diagnostic precision.

Meteoric Resources faces a delay in the approval of its Preliminary Environmental Licence for the Caldeira Rare Earth Project in Brazil, with a rescheduled vote set for mid-December. The company remains confident that all regulatory concerns have been addressed and anticipates minimal impact on project timelines.

Alara Resources is transitioning its Al Wash-hi project to production, targeting over $100 million in revenue for 2025 amid rising global copper demand. Exploration advances in Oman signal further growth potential.

Delorean Corporation marks a pivotal shift to build-own-operate bioenergy projects with the completion of its $53 million Yarra Valley Water facility and strong progress on its SA1 Salisbury project, backed by $51.5 million in financing and robust market demand.

HITIQ Limited is set to introduce its PROTEQT™ concussion management system through rebel, Australia's largest sporting goods retailer, marking a strategic entry into mainstream consumer retail channels starting January 2026.

Polymetals Resources has bolstered its financial position with new loan facilities and option exercises following a fatal incident at its Endeavor Mine, which has now resumed continuous operations.

Corazon Mining has secured two critical tenements at its Two Pools Gold Project in Western Australia, enabling preparations for a maiden diamond drilling program aimed at confirming high-grade gold mineralisation early next year.

Aquirian’s subsidiary TBS Mining Solutions has inked a $4.2 million deal with Papyrus Australia to manufacture biodegradable Collar Keeper® products, marking a significant step in sustainable mining practices.

NRW Holdings reported robust FY25 results with $3.3 billion revenue and $207.9 million underlying EBITA, boosted by strategic acquisitions including Fredon Industries. The company raised its FY26 guidance, projecting revenue near $4.1 billion and EBITA between $260 million and $265 million, underpinned by a $20.9 billion project pipeline.

Altech Batteries has completed the final design of its next-generation Sodium Nickel Chloride UPS battery system, setting the stage for factory testing and trial deployments across the Netherlands. This milestone marks a significant step toward broader European commercialisation.

Imugene Limited and JW Therapeutics have launched a strategic collaboration to combine oncolytic virus and CAR-T cell therapies, aiming to tackle refractory solid tumors through a pioneering 'mark and kill' approach.

Advanced Innergy Holdings Ltd (ASX, AIH) reported unaudited proforma FY25 results exceeding prospectus forecasts, driven by strong organic growth and the strategic acquisition of Ovun. The company reaffirms its FY26 guidance, supported by a robust orderbook and pipeline.